Emergent BioSolutions Inc (EBS)
2.04
+0.18
(+9.68%)
USD |
NYSE |
Apr 19, 16:00
2.06
+0.02
(+0.98%)
After-Hours: 20:00
Emergent BioSolutions Market Cap: 106.49M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 97.10M |
| April 17, 2024 | 99.19M |
| April 16, 2024 | 101.80M |
| April 15, 2024 | 103.36M |
| April 12, 2024 | 107.54M |
| April 11, 2024 | 114.33M |
| April 10, 2024 | 116.41M |
| April 09, 2024 | 120.59M |
| April 08, 2024 | 121.11M |
| April 05, 2024 | 119.55M |
| April 04, 2024 | 118.50M |
| April 03, 2024 | 117.98M |
| April 02, 2024 | 112.76M |
| April 01, 2024 | 120.07M |
| March 28, 2024 | 132.07M |
| March 27, 2024 | 135.21M |
| March 26, 2024 | 127.38M |
| March 25, 2024 | 132.60M |
| March 22, 2024 | 125.81M |
| March 21, 2024 | 128.94M |
| March 20, 2024 | 131.03M |
| March 19, 2024 | 128.42M |
| March 18, 2024 | 128.94M |
| March 15, 2024 | 127.90M |
| March 14, 2024 | 122.68M |
| Date | Value |
|---|---|
| March 13, 2024 | 116.94M |
| March 12, 2024 | 121.63M |
| March 11, 2024 | 146.17M |
| March 08, 2024 | 140.43M |
| March 07, 2024 | 144.60M |
| March 06, 2024 | 170.18M |
| March 05, 2024 | 178.01M |
| March 04, 2024 | 165.48M |
| March 01, 2024 | 176.97M |
| February 29, 2024 | 168.62M |
| February 28, 2024 | 167.05M |
| February 27, 2024 | 172.26M |
| February 26, 2024 | 148.77M |
| February 23, 2024 | 143.03M |
| February 22, 2024 | 146.16M |
| February 21, 2024 | 141.46M |
| February 20, 2024 | 79.34M |
| February 16, 2024 | 81.43M |
| February 15, 2024 | 88.74M |
| February 14, 2024 | 88.22M |
| February 13, 2024 | 83.00M |
| February 12, 2024 | 93.96M |
| February 09, 2024 | 82.48M |
| February 08, 2024 | 87.70M |
| February 07, 2024 | 78.30M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
78.30M
Minimum
Feb 07 2024
7.142B
Maximum
Aug 13 2020
2.347B
Average
2.300B
Median
Feb 08 2022
Market Cap Benchmarks
| Avid Bioservices Inc | 404.73M |
| Viking Therapeutics Inc | 6.363B |
| FibroGen Inc | 113.09M |
| Avinger Inc | 6.775M |
| RAPT Therapeutics Inc | 275.95M |
Market Cap Related Metrics
| PS Ratio | 0.102 |
| PEG Ratio | -0.0007 |
| Price to Book Value | 0.1640 |
| Price | 2.04 |
| Earnings Yield | -723.5% |
| PEGY Ratio | -0.0007 |